![NeoGenomics Europe S.A. Opens its Doors in Rolle, Switzerland Laboratory Hosting Business Leaders, Dignitaries and Local Government Officials :: NeoGenomics, Inc. (NEO) NeoGenomics Europe S.A. Opens its Doors in Rolle, Switzerland Laboratory Hosting Business Leaders, Dignitaries and Local Government Officials :: NeoGenomics, Inc. (NEO)](http://www.marketwire.com/library/MwGo/2017/11/8/11G147639/Images/MultimediaAsset1-298797937.jpg)
NeoGenomics Europe S.A. Opens its Doors in Rolle, Switzerland Laboratory Hosting Business Leaders, Dignitaries and Local Government Officials :: NeoGenomics, Inc. (NEO)
![Lab testing giant, approaching $500M in revenue, welcomes new CEO | Business Observer | Business Observer Lab testing giant, approaching $500M in revenue, welcomes new CEO | Business Observer | Business Observer](https://www.businessobserverfl.com/sites/default/files/402207_standard.jpeg)
Lab testing giant, approaching $500M in revenue, welcomes new CEO | Business Observer | Business Observer
![NeoGenomics Europe S.A. Opens its Doors in Rolle, Switzerland Laboratory Hosting Business Leaders, Dignitaries and Local Government Officials | World Pharma Today NeoGenomics Europe S.A. Opens its Doors in Rolle, Switzerland Laboratory Hosting Business Leaders, Dignitaries and Local Government Officials | World Pharma Today](https://www.worldpharmatoday.com/wp-content/uploads/2017/11/images_article_pressrelease_Neogenomics-europe.jpg)
NeoGenomics Europe S.A. Opens its Doors in Rolle, Switzerland Laboratory Hosting Business Leaders, Dignitaries and Local Government Officials | World Pharma Today
![NeoGenomics Launches Comprehensive Suite of Solid Tumor Liquid Biopsy Tests for Cancer Patients | AP News NeoGenomics Launches Comprehensive Suite of Solid Tumor Liquid Biopsy Tests for Cancer Patients | AP News](https://storage.googleapis.com/afs-prod/media/e2b035487b69724645783394f732a437/600.jpeg)
NeoGenomics Launches Comprehensive Suite of Solid Tumor Liquid Biopsy Tests for Cancer Patients | AP News
![Elevation Oncology and NeoGenomics Announce Collaboration to Expand Genomic Testing for NRG1 Fusions Across Solid Tumors in Support of the Phase 2 CRESTONE Study - Mar 16, 2021 Elevation Oncology and NeoGenomics Announce Collaboration to Expand Genomic Testing for NRG1 Fusions Across Solid Tumors in Support of the Phase 2 CRESTONE Study - Mar 16, 2021](https://mma.prnewswire.com/media/1456804/Elevation_Oncology_and_NeoGenomics_Logo.jpg?p=facebook)